This Article Free upon publication Full Text Full Text (PDF) All Versions of this Article: 118/20/2022    most recent CIRCULATIONAHA.107.748962v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gold, M. R. Articles by Bardy, G. H. Search for Related Content PubMed PubMed Citation Articles by Gold, M. R. Articles by Bardy, G. H. Related Collections Congestive Electrocardiology Ablation/ICD/surgery Related Article

(Circulation. 2008;118:2022-2028.)
© 2008 American Heart Association, Inc.

Arrhythmia/Electrophysiology

Role of Microvolt T-Wave Alternans in Assessment of Arrhythmia Vulnerability Among Patients With Heart Failure and Systolic Dysfunction

Primary Results From the T-Wave Alternans Sudden Cardiac Death in Heart Failure Trial Substudy

Michael R. Gold, MD, PhD; John H. Ip, MD; Otto Costantini, MD; Jeanne E. Poole, MD; Steven McNulty, MS; Daniel B. Mark, MD; Kerry L. Lee, PhD; Gust H. Bardy, MD

From Medical University of South Carolina (M.R.G.,), Charleston, SC; Michigan State University (J.H.I.), East Lansing, Mich; MetroHealth Campus/Case Western Reserve University (O.C.), Cleveland, Ohio; University of Washington (J.E.P., G.H.B.), Seattle, Wash; Duke University (S.M., D.B.M., K.L.L.), Durham, NC; and Seattle Institute for Cardiac Research (G.H.B.), Seattle, Wash.

Correspondence to Michael R. Gold, MD, PhD, Division of Cardiology, Medical University of South Carolina, 25 Courtenay Dr, ART 7031, Charleston, SC 29425-5920. E-mail goldmr{at}musc.edu

Received November 14, 2007; accepted August 29, 2008.

Background— Sudden cardiac death remains a leading cause of mortality despite advances in medical treatment for the prevention of ischemic heart disease and heart failure. Recent studies showed a benefit of implantable cardioverter defibrillator implantation, but appropriate shocks for ventricular tachyarrhythmias were noted only in a minority of patients during 4 to 5 years of follow-up. Accordingly, better risk stratification is needed to optimize patient selection. In this regard, microvolt T-wave alternans (TWA) has emerged as a potentially useful measure of arrhythmia vulnerability, but it has not been evaluated previously in a prospective, randomized trial of implantable cardioverter defibrillator therapy.

Methods and Results— This investigation was a prospective substudy of the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) that included 490 patients at 37 clinical sites. TWA tests were classified by blinded readers as positive (37%), negative (22%), or indeterminate (41%) by standard criteria. The composite primary end point was the first occurrence of any of the following events: sudden cardiac death, sustained ventricular tachycardia/fibrillation, or appropriate implantable cardioverter defibrillator discharge. During a median follow-up of 30 months, no significant differences in event rates were found between TWA-positive or -negative patients (hazard ratio 1.24, 95% confidence interval 0.60 to 2.59, P=0.56) or TWA-negative and nonnegative (positive and indeterminate) subjects (hazard ratio 1.28, 95% confidence interval 0.65 to 2.53, P=0.46). Similar results were obtained with the inclusion or exclusion of patients randomized to amiodarone in the analyses.

Conclusions— TWA testing did not predict arrhythmic events or mortality in SCD-HeFT, although a small reduction in events (20% to 25%) among TWA-negative patients cannot be excluded given the sample size of this study. Accordingly, these results suggest that TWA is not useful as an aid in clinical decision making on implantable cardioverter defibrillator therapy among patients with heart failure and left ventricular systolic dysfunction.

---

 

CLINICAL PERSPECTIVE

Related Article:

Clinical Summaries
Circulation 2008 118: 2013-2014. [Extract] [Full Text]

This article has been cited by other articles:

				W. C. Levy, K. L. Lee, A. S. Hellkamp, J. E. Poole, D. Mozaffarian, D. T. Linker, A. P. Maggioni, I. Anand, P. A. Poole-Wilson, D. P. Fishbein, et al. Maximizing Survival Benefit With Primary Prevention Implantable Cardioverter-Defibrillator Therapy in a Heart Failure Population Circulation, September 8, 2009; 120(10): 835 - 842. [Abstract] [Full Text] [PDF]

				G. M. Marcus, E. Keung, and M. M. Scheinman The year in review of clinical cardiac electrophysiology. J. Am. Coll. Cardiol., August 25, 2009; 54(9): 777 - 787. [Full Text] [PDF]

				G. M. De Ferrari and R. L. Verrier Letter by De Ferrari and Verrier Regarding Article, "Role of Microvolt T-Wave Alternans in Assessment of Arrhythmia Vulnerability Among Patients With Heart Failure and Systolic Dysfunction: Primary Results From the T-Wave Alternans Sudden Cardiac Death in Heart Failure Trial Substudy" Circulation, July 21, 2009; 120(3): e20 - e20. [Full Text] [PDF]

				J. E. Madias Letter by Madias Regarding Article, "Role of Microvolt T-Wave Alternans in Assessment of Arrhythmia Vulnerability Among Patients With Heart Failure and Systolic Dysfunction: Primary Results From the T-Wave Alternans Sudden Cardiac Death in Heart Failure Trial Substudy" Circulation, July 21, 2009; 120(3): e21 - e21. [Full Text] [PDF]

				M. R. Gold, J. H. Ip, O. Costantini, J. E. Poole, G. H. Bardy, S. McNulty, D. B. Mark, and K. L. Lee Response to Letters Regarding Article, "Role of Microvolt T-Wave Alternans in Assessment of Arrhythmia Vulnerability Among Patients With Heart Failure and Systolic Dysfunction: Primary Results From the T-Wave Alternans Sudden Cardiac Death in Heart Failure Trial Substudy" Circulation, July 21, 2009; 120(3): e22 - e22. [Full Text] [PDF]

				F. G. Hage, R. Venkataraman, G. J. Zoghbi, G. J. Perry, A. M. DeMattos, and A. E. Iskandrian The scope of coronary heart disease in patients with chronic kidney disease. J. Am. Coll. Cardiol., June 9, 2009; 53(23): 2129 - 2140. [Abstract] [Full Text] [PDF]

				J. E. Madias Microvolt T-wave alternans is there anything that can be done to save it? J. Am. Coll. Cardiol., April 7, 2009; 53(14): 1245 - 1246. [Full Text] [PDF]

				T. Chow and B. J. Peterson Reply. J. Am. Coll. Cardiol., April 7, 2009; 53(14): 1246 - 1247. [Full Text] [PDF]

				E. J. Rashba Anger management may save your life new insights into emotional precipitants of ventricular arrhythmias. J. Am. Coll. Cardiol., March 3, 2009; 53(9): 779 - 781. [Full Text] [PDF]

				D. S. Rosenbaum T-Wave Alternans in the Sudden Cardiac Death in Heart Failure Trial Population: Signal or Noise? Circulation, November 11, 2008; 118(20): 2015 - 2018. [Full Text] [PDF]